Advances in Cancer Immunotherapy™: A Focus on Biomarkers

When:  Mar 24, 2022 from 16:00 to 20:15 (PT)
This program will be hosted virtually.


(Nora) Mary L. Disis, MD, FACP – University of Washington
Andrew Coveler, MD – University of Washington/Fred Hutchinson Cancer Research Center

Program Learning Objectives 

  • Discuss biomarkers in clinical use with approved cancer immunotherapies.
  • Summarize recent updates in the use of biomarkers for cancer immunotherapies.
  • Implement the use of biomarkers to select appropriate treatments for patients with cancer.

For more information on the program, click below.


View the SITC Meeting Code of Conduct.